Oligoclonal Bands in Patients With Multiple Myeloma: Its Emergence Per Se Could Not Be Translated to Improved Survival

Cancer Science - United States
doi 10.1111/cas.12527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib

Blood Cancer Journal
OncologyHematology
2015English

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma

JAMA Oncology
Cancer ResearchOncology
2017English

Responses in Multiple Myeloma Should Be Assigned According to Serum, Not Urine, Free Light Chain Measurements

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Differences in Oligoclonal Bands and Visual Evoked Potentials in Patients With Radiologically and Clinically Isolated Syndrome

Acta Neurologica Belgica
MedicineNeurology
2012English

Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Should We Be Routinely Testing for Circulating Clonal Plasma Cells in Patients With Multiple Myeloma?

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2018English

Residual Serum Monoclonal Protein Predicts Progression-Free Survival in Patients With Previously Untreated Multiple Myeloma

Cancer
Cancer ResearchOncology
2010English

Blood Distribution of Bortezomib and Its Kinetics in Multiple Myeloma Patients

Clinical Biochemistry
MedicineClinical Biochemistry
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy